Category: LensAR Inc.Syndicate content

LensAR raises $8M for laser eye surgery

August 4, 2014 by Arezu Sarvestani

LensAR secures another $8 million in an equity funding round in support of its laser-based cataract surgery systems.

LensAR raises $8M for laser eye surgery

Opthalmology devices maker LensAR secured $8 million in equity funding, according to an SEC filing dated July 31, 2014.

LensAR closes $10M equity funding round

January 9, 2014 by Arezu Sarvestani

Florida medical device maker LensAR raises $10 million from 14 unnamed investors, regulatory filings show.

LensAR closes $10M equity funding round

Orlando, Fla.-based cataract surgery technology company LensAR closed an equity funding round with $10 million raised from 14 investors, regulatory documents show.

The fundraising effort, launched in December, was closed yesterday and use of the proceeds was not described, outside of an estimated $370,000 listed in payments to individuals listed as "executive officers, directors or promoters" of the company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

LensAR launches U.K. clinical trial of laser-based eye surgery

November 19, 2013 by Arezu Sarvestani

Florida medical device maker LensAR touts the launch of a U.K. clinical trial evaluating its laser system in treatment of patients with presbyopia.

LensAR launches U.K. clinical trial of laser-based eye surgery

Orlando, Fla.-based LensAR Inc. announced the launch of a new U.K. clinical trial, evaluating the company's laser-based lens softening system in treatment of patients with presbyopia.

The study begins with enrollment of the 1st 30 patients and will expand to more sites by the end of the year, LensAR said.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

LensAR raises $87M for laser cataract surgery system

October 2, 2013 by Arezu Sarvestani

Florida laser cataract surgery technology company LensAR touts $87 million raised through private equity and debt financing.

Lensar raises $87M for laser cataract surgery system

Orlando, Fla.-based medical device company LensAR Inc. touted $87 million in fundraising, mostly through a debt financing agreement, in support of its laser cataract surgery systems.

LensAR raised $27 million in private equity financing and secured up to $60 million in debt financing. The company plans to use the funds to advance commercialization worldwide and to advance development of its cataract surgery platform.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

LensAR seeks $19.8M for laser cataract surgery systems

August 26, 2013 by Arezu Sarvestani

Florida opthalmology devices maker LensAR raises $2.3 million of a hoped-for $19.8 million in equity funding.

LensAR seeks $19.8M for laser cataract surgery systems

Orlando, Fla.-based LensAR has raised $2.3 million so far among 3 unnamed investors, hoping to hit $19.8 million in equity funding, according to documents filed with the SEC.

The fundraising round, launched at the start of the month, isn't independent of any other business transaction, the company noted.

LensAR lands another FDA clearance for cataract laser surgery

April 3, 2013 by Brad Perriello

The FDA grants 510(k) clearance to LensAR's laser surgery system for a type of incision made during cataract surgeries.

Lensar

The laser cataract surgery market has another player, now that the FDA's cleared its laser surgery device for another type of incision used during cataract surgery procedures.

LensAR said it won 510(k) clearance from the FDA for its laser cataract surgery device for arcuate incisions to the edge of the cornea.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

LensAR wins FDA clearance for its next-gen laser system

December 27, 2012 by MassDevice staff

The FDA OKs LensAR's laser system for executing corneal incisions, giving the system full indications for all the critical components of laser cataract surgery.

LensAR logo

Orlando, Fla.-based LensAR won additional FDA clearance for its next-generation LensAR laser system, gaining indication for performing corneal incisions during cataract surgery.

With the latest regulatory win the LensAR system is cleared for all critical aspects of laser cataract surgery, including lens fragmentation, anterior capsulotomy and corneal incisions, according to the press release.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp